الملخص
Our objective is to report a case of bilateral nodular scleritis in a 34-year-old patient, resistant to steroids and traditional disease modifying anti-rheumatic drugs, who was successfully treated with subcutaneous injections of 40 mg adalimumab. Adalimumab resulted in rapid control of scleritis in both eyes within 3 months with no recurrence over 5 years of follow-up. No side effects were reported during treatment.Although a large prospective study and a longer follow-up are required to reach a conclusive result, adalimumab has a potential role in the treatment of the above condition with the control of inflammation.
الكلمات المفتاحية
بيانات النشر
- المعرّف الرقمي
- 10.4103/0974-620x.91271
- المجلة
- المجلة العُمانية لطب العيون, 4(3), 139-141
- الناشر
- منشورات ميدنو
- وصول مفتوح
- وصول مفتوح ذهبي
اقتبس هذه المقالة
APA 7
Bawazeer, A. M., & Raffa, L. H. (2011). Adalimumab in the treatment of recurrent idiopathic bilateral nodular scleritis. Oman Journal of Ophthalmology, 4(3), 139-141. https://doi.org/10.4103/0974-620x.91271
MLA 9
Bawazeer, Ahmed M, and Lina H Raffa. "Adalimumab in the treatment of recurrent idiopathic bilateral nodular scleritis." Oman Journal of Ophthalmology, vol. 4, no. 3, 2011, pp. 139-141. https://doi.org/10.4103/0974-620x.91271.
شيكاغو (المؤلف–التاريخ)
Bawazeer, Ahmed M, and Lina H Raffa. 2011. "Adalimumab in the treatment of recurrent idiopathic bilateral nodular scleritis." Oman Journal of Ophthalmology 4 (3): 139-141. https://doi.org/10.4103/0974-620x.91271.
هارفارد
Bawazeer, A. M. and Raffa, L. H. (2011) 'Adalimumab in the treatment of recurrent idiopathic bilateral nodular scleritis', Oman Journal of Ophthalmology, 4(3), pp. 139-141. doi:10.4103/0974-620x.91271.
فانكوفر
Bawazeer AM, Raffa LH. Adalimumab in the treatment of recurrent idiopathic bilateral nodular scleritis. Oman Journal of Ophthalmology. 2011;4(3):139-141. doi:10.4103/0974-620x.91271
IEEE
A. M. Bawazeer, and L. H. Raffa, "Adalimumab in the treatment of recurrent idiopathic bilateral nodular scleritis," Oman Journal of Ophthalmology, vol. 4, no. 3, pp. 139-141, 2011, doi: 10.4103/0974-620x.91271.